This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boden, W. E. Search for Related Content PubMed PubMed Citation Articles by Boden, W. E.

Surgery, angioplasty, or medical therapy for symptomatic multivessel coronary artery disease

Is there an indisputable "winning strategy" from evidence-based clinical trials?^*

^a Division of Cardiology, the Henry Low Heart Center at Hartford Hospital, Hartford, Connecticut, USA
^b University of Connecticut School of Medicine, Farmington, Connecticut, USA

View larger version (28K): [in a new window]   Figure 1 Risk ratios and 95% confidence intervals (CI) for percutaneous transluminal coronary angioplasty (PTCA) versus medical therapy among the randomized clinical trials in patients with stable angina and coronary artery disease. End points of interest include angina relief, fatal and non-fatal myocardial infarction, death, need for subsequent coronary artery bypass graft (CABG) surgery and subsequent PTCA. Reprinted, with permission, from Brophy et al. (14).